Condition
Revision
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 65/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed2
Terminated2
Active Not Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05002959Terminated
TESS V3 Modular Total Shoulder System PMCF
NCT03423953Active Not Recruiting
Comprehensive Nano - Post Market Clinical Follow-Up Study
NCT07232771Completed
Reinfection and Re-revision Rates of Periprosthetic Knee Infection Under Four Different Surgical Strategies
NCT02865928Phase 4Terminated
Serratus Plane Block for Postoperative Pain Control
NCT03431857Completed
Multi Centre Study on TESS V2 Shoulder System
Showing all 5 trials